<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390659</url>
  </required_header>
  <id_info>
    <org_study_id>khalid7</org_study_id>
    <nct_id>NCT04390659</nct_id>
  </id_info>
  <brief_title>Myomectomy During Cesarean Section Is This Aright Decision</brief_title>
  <official_title>Myomectomy During Cesarean Section,Is This Aright Decision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      myomectomy was done during cesarean section
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The myomectomy was done by conventional technique but timing of myomectomy either before or
      after delivery of the baby varied between different cases .Infusion of oxytocin during the
      operation and for 24 h later.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2014</start_date>
  <completion_date type="Actual">September 15, 2019</completion_date>
  <primary_completion_date type="Actual">March 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>difficulty of cesarean myomectomy</measure>
    <time_frame>during the procedure/surgery&quot;</time_frame>
    <description>according to the site and type of myoma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>4concentrations of hemoglobin</measure>
    <time_frame>during the procedure</time_frame>
    <description>intra operative bleeding</description>
  </secondary_outcome>
  <enrollment type="Actual">45</enrollment>
  <condition>Obstetric Labor, Premature</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>myomectomy</intervention_name>
    <description>The myomectomy was done by conventional technique but timing of myomectomy either before or after delivery of the baby varied between different cases .Infusion of oxytocin during the operation and for 24 h later.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        c s with uterine myoma
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with diagnosed uterine myoma prior to pregnancy

          -  needed cesarean sections for various indications.

          -  Women with diagnosed uterine myoma during pregnancy and needed cesarean sections for
             various indications.

          -  Women with myoma diagnosed incidentally during labour.

        Exclusion Criteria:

          -  Refusal of the women at any time before and during the operations.

          -  Cervical myoma.

          -  Atonic uterus after delivery of the baby.

          -  Women with bleeding disorders due to medical or obstetric causes.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>khalid salama</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <results_reference>
    <citation>Lédée-Bataille N, Laprée-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod. 2002 Jan;17(1):213-8.</citation>
    <PMID>11756390</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 29, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>khalid mohammed salama</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>master sheet</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

